Anebulo Pharmaceuticals (ANEB) Shares Outstanding (Diluted) (2022 - 2025)
Anebulo Pharmaceuticals (ANEB) reported Shares Outstanding (Diluted) of 41.08 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 49.9% from 27.42 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Shares Outstanding (Diluted) (2022 - 2025) Analysis & Trends
For FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals posted Shares Outstanding (Diluted) of 33.82 million, up 31.0% from FY2024.
- Shares Outstanding (Diluted) has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 13.2% (FY2022 to FY2025).
- By fiscal year, Shares Outstanding (Diluted) came in at 25.82 million in FY2024 (+3.0%), 25.07 million in FY2023 (+7.4%) and 23.34 million in FY2022.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last 11 quarters, with growth averaging 26.2% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.6% (fiscal Q2 2024) and 58.4% (fiscal Q1 2026) over the last five years.
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at 41.08 million (Q1 2026), 33.82 million (Q4 2025) and 41.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Anebulo Pharmaceuticals | 11.91 Mn | -32.39 Mn | - | 41.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 41.08 Mn |
| Sep 30, 2025 | 41.08 Mn |
| Jun 30, 2025 | 33.82 Mn |
| Mar 31, 2025 | 41.08 Mn |
| Dec 31, 2024 | 27.42 Mn |
| Sep 30, 2024 | 25.93 Mn |
| Jun 30, 2024 | 25.82 Mn |
| Mar 31, 2024 | 25.93 Mn |
| Dec 31, 2023 | 25.79 Mn |
| Sep 30, 2023 | 25.63 Mn |
| Jun 30, 2023 | 25.07 Mn |
| Mar 31, 2023 | 25.63 Mn |
| Dec 31, 2022 | 25.63 Mn |
| Sep 30, 2022 | 23.42 Mn |
| Jun 30, 2022 | 23.34 Mn |
API Access
Anebulo Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();